ALT: Altimmune, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 457.04
Enterprise Value ($M) 341.43
Book Value ($M) 79.52
Book Value / Share 2.42
Price / Book 5.09
NCAV ($M) 64.95
NCAV / Share 1.97
Price / NCAV 6.23

Profitability (mra)
Return on Invested Capital (ROIC) -0.43
Return on Assets (ROA) -0.37
Return on Equity (ROE) -0.42

Liquidity (mrq)
Quick Ratio n/a
Current Ratio 17.89

Balance Sheet (mrq) ($M)
Current Assets 87.97
Assets 102.54
Liabilities 23.02
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue n/a
Operating Income -21.46
Net Income -20.52
Earnings Per Share Basic And Diluted -1.60
Earnings Per Share Diluted -1.60
Earnings Per Share Basic -1.60

Cash Flow Statement (mra) ($M)
Cash From Operations -9.60
Cash from Investing -28.29
Cash from Financing -28.29

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2020-10-05 13G D. E. Shaw & Co, L.p. 5.00 0.09
2020-06-25 13D Venrock Healthcare Capital Partners II, L.P. 20.80 50.00
2020-02-14 13G Velocity Pharmaceutical Holdings Llc 12.30
2020-02-11 13G/A Intracoastal Capital, Llc 3.10 -9.96
2020-01-31 13G/A Hudson Bay Capital Management LP 9.99 75.23
2019-02-14 13G/A CVI Investments, Inc. 4.90 82.07
2019-02-11 13G/A Ofco Club V 0.70 -95.32
2019-02-05 13G/A Novartis Bioventures Ltd 3.50 11.15
2018-02-14 13G/A Renaissance Technologies Llc 4.02 -81.22
2018-02-09 13G/A Truffle Capital S.a.s. 10.30 26.88
2017-10-19 13D/A Hodges Philip 3.70 -55.77
2017-02-14 13G/A Nantahala Capital Management, LLC 4.80 -5.53
2017-02-10 13G/A Prescott Group Capital Management, L.l.c. 4.90
2016-10-19 13G JFL Capital Management, LLC 5.05
2016-03-30 13D/A Mpm Bioventures Iii L.p. 0.00 -100.00
2013-08-12 13D Theraclone Sciences, Inc. 7.60

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2020-08-11 10-Q Quarterly Report – 10-Q
2020-05-13 10-Q Form 10-Q
2020-03-27 10-K Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2020-12-01 2,523,136 8,211,100 30.73
2020-11-30 583,030 3,690,092 15.80
2020-11-27 197,693 1,464,283 13.50

(click for more detail)

Similar Companies
ALNY – Alnylam Pharmaceuticals, Inc. ALPN – Alpine Immune Sciences Inc
ALRN – Aileron Therapeutics Inc. ALXA – Alexza Pharmaceuticals, Inc.
ALXN – Alexion Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io